Shixuan Wang

机构：Harbin Engineering University, Anhui University of Science and Technology, China University of Mining and Technology, National Clinical Research Center for Digestive Diseases, Harbin Electric Corporation (China), National Clinical Research, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Ministry of Education, Tongji Hospital, Huazhong University of Science and Technology, University of Cincinnati, Henan Normal University · ORCID：0000-0002-8610-952X

发表论文 370 篇 · 总被引 8734 次 · h-index 51

代表论文

• Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes (2025 · Nature Medicine · 被引 33)
• Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions (2025 · MedComm · 被引 16)
• The role and mechanisms of myokines in sarcopenia: new intervention strategies for the challenges of aging (2025 · Frontiers in Medicine · 被引 15)
• Author Correction: Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes (2025 · Nature Medicine · 被引 7)
• Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors (2025 · Annals of Oncology · 被引 5)
• Modulating IL-11-dependent matrix stiffness to delay ovarian aging (2026 · Nature Aging · 被引 3)